
Sign up to save your podcasts
Or


In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.
By American College of Cardiology4.4
3737 ratings
In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.

321 Listeners

504 Listeners

167 Listeners

41 Listeners

906 Listeners

21 Listeners

3 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

65 Listeners

367 Listeners

19 Listeners

437 Listeners

32 Listeners